文献速递血管炎

持续疾病不活动的大动脉炎患者停用免疫抑制治疗

Cessation of immunosuppressive therapies in patients with Takayasu arteritis with sustained inactive disease.
PubMed 文献 · Semin Arthritis Rheum · 2021-12-31

该回顾性单中心研究纳入多伦多三级血管炎门诊65例大动脉炎患者,随访至2021年1月且诊断后至少2年,发现38.5%患者成功停用免疫抑制治疗超过6个月,停药组诊断时CRP更低、肾动脉受累更少、病程更长。

要点

  • 38.5%的大动脉炎患者成功停用免疫抑制治疗超过6个月且疾病保持不活动。
  • 停药组诊断时中位CRP为16.4 mg/L,低于继续治疗组的45 mg/L(P=0.023)。
  • 停药组左肾动脉受累更少见(P=0.035),中位病程18年长于继续治疗组的9年(P=0.004)。

核心结论

  • 约三分之一的大动脉炎患者能够停用治疗,其诊断时CRP水平较低、肾动脉受累较少且病程较长。
  • 除上述特征外,未见其他特定疾病特征有助于识别成功减停治疗机会更大的患者。

研究设计与样本

  • 回顾性单中心分析,纳入多伦多三级血管炎门诊自建库至2021年1月随访、且诊断后至少2年的大动脉炎患者65例(95.4%为女性,46.7%为白人)。

主要发现

  • 25例(38.5%)患者在末次随访时已成功停用免疫抑制治疗超过6个月且疾病保持不活动。
  • 停药组中位病程18年(IQR 10-23年),继续治疗组9年(IQR 5.3-16.0年),P=0.004。
  • 停药组诊断时中位CRP为16.4 mg/L(IQR 5.4-32.2 mg/L),继续治疗组为45 mg/L(IQR 15.0-75.5 mg/L),P=0.023。
  • 停药组肾动脉受累更少见,尤其是左肾动脉受累(P=0.035)。
  • 两组其他疾病特征比较未见差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Takayasu arteritis (TA) is a chronic and relapsing vasculitis. The objectives of this study were to describe the characteristics and identify predictive factors associated with successful treatment discontinuation in a cohort of patients with TA. METHODS: We conducted a retrospective monocentric analysis of patients with TA, followed at the tertiary Vasculitis Clinic in Toronto, from inception to January 2021, and for at least 2 years after diagnosis. The objectives were to determine the frequency of patients whose immunosuppressive medications had been stopped for at least 6 months before their last follow-up visit and whose disease remained inactive, and analyze their characteristics, in comparison with the remaining of the cohort still on medications for TA. RESULTS: The cohort included 65 patients (95.4% women; 46.7% white). Twenty-five (38.5%) patients had successfully discontinued their treatment for more than 6 months at their last visit. Median disease duration was 18 years (IQR, 10-23 years) in the group off treatment, compared to 9 years (IQR, 5.3-16.0 years) in the group still on treatment (P = 0.004). Renal artery involvement was less frequent in patients who had stopped their immunosuppressants, especially left renal artery (P = 0.035). Median CRP level at diagnosis was 16.4 mg/L (IQR, 5.4-32.2 mg/L) in the group off treatment, and 45 mg/L (IQR, 15.0-75.5 mg/L) in the group on treatment (P = 0.023). No other difference was found when comparing disease characteristics of the two groups, on or off medications. CONCLUSION: One third of TA patients were able to discontinue their treatment. They had lower CRP levels at diagnosis, less frequent renal artery involvement and longer disease duration. No other specific disease features seem to help identify patients with greater chances to be weaned off treatment successfully.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Ross C, Lefebvre F, Pagnoux C, et al. Cessation of immunosuppressive therapies in patients with Takayasu arteritis with sustained inactive disease. Semin Arthritis Rheum. 2021. PMID: 35000787. doi:10.1016/j.semarthrit.2021.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。